Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ARN22089
i
Other names:
ARN22089
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
University of California
Drug class:
CDC42 inhibitor
Related drugs:
‹
MBQ-167 (0)
MBQ-167 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF mutation
Melanoma
BRAF mutation
Melanoma
ARN22089
Sensitive: D – Preclinical
ARN22089
Sensitive
:
D
ARN22089
Sensitive: D – Preclinical
ARN22089
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.